Search

everythinglearnresearchcommunity

for

Search:↓

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Hormone treatment for transsexual individuals is effective but carries risks like thromboembolic events and mood changes, with most side effects being minor and reversible.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Cyproterone acetate reduces hair growth and oil production.

Hormones control keratin production in skin and hair.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Lichen planopilaris (LPP) is linked to androgen excess, while frontal fibrosing alopecia (FFA) is linked to androgen deficiency.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Male rats grow hair faster than females, and certain hormones can slow or slightly increase hair growth, but not significantly beyond natural rates.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Losing 5-10% body weight can improve PCOS symptoms, letrozole is better than clomiphene for fertility, and managing weight and blood sugar is important to reduce pregnancy complications.

Topical finasteride doesn't reduce DHT levels, hinting at an endocrine role in hair loss.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Topical spironolactone cream doesn't cause hormone-related side effects in the body.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Old drugs are often used for new, different medical purposes in endocrine pharmacology.